Morphine Bioavailability from a Topical Gel Formulation in Volunteers

Journal of Pain and Symptom Management

Volumn 35, Issue 3, 2008, Pages 314-320

  Paice, Judith A ^a   Von Roenn, Jamie H ^a   Hudgins, J Craig ^a   Luong, Lynn ^a   Krejcie, Tom C ^a   Avram, Michael J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

bioavailability; Cancer related pain; morphine; pharmacokinetics; pluronic lecithin organogel (PLO) base; randomized controlled trial; topical formulation; volunteers

Indexed keywords

MORPHINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; RANDOMIZED CONTROLLED TRIAL; SOLID PHASE EXTRACTION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANALGESICS, OPIOID; CHEMISTRY, PHARMACEUTICAL; FEMALE; GELS; HUMANS; MALE; MORPHINE; NEOPLASMS; PAIN;

EID: 39449109178     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2007.04.016     Document Type: Article

References (25)

1. Mercadante S., and Fulfaro F. Alternatives to oral opioids for cancer pain. Oncology (Williston Park) 13 (1999) 215-220
2. Papich M.G. Drug compounding for veterinary patients. AAPS J 7 (2005) E281-E287
3. Kumar R., and Katare O.P. Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review. AAPS PharmSciTech 6 (2005) E298-E310
4. Krajnik M., Zylicz Z., Finlay I., Luczak J., and Van Sorge A.A. Potential uses of topical opioids in palliative care-report of 6 cases. Pain 80 (1999) 121-125
5. Wilken M., Ineck J.R., and Rule A.M. Chronic arthritis pain management with topical morphine: case series. J Pain Palliat Care Pharmacother 19 (2005) 39-44
6. Stuart-Harris R., Joel S.P., McDonald P., Currow D., and Slevin M.L. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Br J Clin Pharmacol 49 (2000) 207-214
7. Avram M.J., Henthorn T.K., Spyker D.A., et al. Recirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogs. Drug Metab Dispos 35 (2007) 262-267
8. Paice J., Von Roenn J., Hudgins J., et al. Topical morphine bioavailability in volunteers. [abstract]. J Pain 8 4 (2007) S48
9. The Hospice Pharmacia Pharmaceutical Care Tool Kit™. 6th ed. (2004), excelleRx, Philadelphia
10. Lugo R.A., and Kern S.E. Clinical pharmacokinetics of morphine. J Pain Palliat Care Pharmacother 16 (2002) 5-18
11. Barrett P.H.R., Bell B.M., Cobelli C., et al. SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism 47 (1998) 484-492
12. Ward M.E., Woodhouse A., Mather L.E., et al. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system. Clin Pharmacol Ther 62 (1997) 596-609
13. Glare P.A., and Walsh T.D. Clinical pharmacokinetics of morphine. Ther Drug Monit 13 (1991) 1-23
14. Vase L., Riley III J.L., and Price D.D. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99 (2002) 443-452
15. Roy S.D., and Flynn G.L. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm Res 6 (1989) 825-832
16. Krotscheck U., Boothe D.M., and Boothe H.W. Evaluation of transdermal morphine and fentanyl pluronic lecithin organogel administration in dogs. Vet Ther 5 (2004) 202-211
17. Ribeiro M.D.C., Joel S.P., and Zeppetella G. The bioavailability of morphine applied topically to cutaneous ulcers. J Pain Symptom Manage 27 (2004) 434-439
18. Zeppetella G., Paul J., and Ribeiro M.D.C. Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage 25 (2003) 555-558
19. Janson W., and Stein C. Peripheral opioid analgesia. Curr Pharm Biotechnol 4 (2003) 270-274
20. Lilleso J., Hammer N.A., Pedersen J.L., and Kehlet H. Effect of peripheral morphine in a human model of acute inflammatory pain. Br J Anaesth 85 (2000) 228-232
21. Westerling D., Höglund P., Lundin S., and Svedman P. Transdermal administration of morphine to healthy subjects. Br J Clin Pharmacol 37 (1994) 571-576
22. Grond S., Radbruch L., and Lehmann K.A. Clinical pharmacokinetics of transdermal opioids: Focus on transdermal fentanyl. Clin Pharmacokinet 38 (2000) 59-89
23. Gourlay G.K., Kowalski S.R., Plummer J.L., et al. The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects. Pain 37 (1989) 193-202
24. Gourlay G.K. Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2 (2001) 165-172
25. Murdan S. A review of pluronic lecithin organogel as a topical and transdermal drug delivery system. Hospital Pharmacist 12 (2005) 267-270